Monitoring neonates for ototoxicity

References

• AAA. 2009. Position Statement and Practice Guidelines: Ototoxicity Monitoring. Reston (VA): American Academy of Audiology.
   Google Scholar
• Abdala, C., Winter, M. & Shera, C.A. 2017. Otoacoustic emissions in infants and children: an updated approach. In: Tharpe, A.M. & Seewald, R.C. (eds.) Comprehensive Handbook of Pediatric Audiology. San Diego (CA): Plural Publishing.
   Google Scholar
• ACMG. 2002. Genetics evaluation guidelines for the etiologic diagnosis of congenital hearing loss. genetic evaluation of congenital hearing loss expert panel. ACMG statement. Genet Med, 4, 162–171.
   PubMed Web of Science ®Google Scholar
• American Academy of Pediatrics C.o.E.H. 1997. Noise: a hazard for the fetus and newborn. Pediatrics, 100, 724–727.
   PubMed Web of Science ®Google Scholar
• ASHA. 1994. Audiologic screening. Ad Hoc Committee on Screening for Impairment, Handicap, and Middle Ear Disorders. American Speech-Language-Hearing Association (ASHA). ASHA, 36, 53–54.
   Google Scholar
• ASHA. 2013. Expert Panel Recommendations on Newborn Hearing Screening. Rockville, MD: American Speech-Language-Hearing Association.
   Google Scholar
• Aust, G. 2001. Vestibulotoxicity and ototoxicity of gentamicin in newborns at risk. Int Tinnitus J, 7, 27–29.
   PubMedGoogle Scholar
• Bates, D.E., Beaumont, S.J. & Baylis, B.W. 2002. Ototoxicity induced by gentamicin and furosemide. Ann Pharmacother, 36, 446–451.
   PubMed Web of Science ®Google Scholar
• Brock, P.R., Knight, K.R., Freyer, D.R., Campbell, K.C., Steyger, P.S., et al. 2012. Platinum-induced ototoxicity in children: a consensus review on mechanisms, predisposition, and protection, including a new International Society of Pediatric Oncology Boston ototoxicity scale. J Clin Oncol, 30, 2408–2417.
   PubMed Web of Science ®Google Scholar
• Brummett, R.E., Fox, K.E., Jacobs, F., Kempton, J.B., Stokes, Z., et al. 1990. Augmented gentamicin ototoxicity induced by vancomycin in guinea pigs. Arch Otolaryngol Head Neck Surg, 116, 61–64.
   PubMed Web of Science ®Google Scholar
• Bryant, J.M., Grogono, D.M., Rodriguez-Rincon, D., Everall, I., Brown, K.P., et al. 2016. Emergence and spread of a human-transmissible multidrug-resistant nontuberculous mycobacterium. Science, 354, 751–757.
   PubMed Web of Science ®Google Scholar
• Camacho-Gonzalez, A., Spearman, P.W. & Stoll, B.J. 2013. Neonatal infectious diseases: evaluation of neonatal sepsis. Pediatr Clin North Am, 60, 367–389.
   PubMed Web of Science ®Google Scholar
• Chang, K.W. 2011. Clinically accurate assessment and grading of ototoxicity. Laryngoscope, 121, 2649–2657.
   PubMed Web of Science ®Google Scholar
• Cheung, P.Y., Tyebkhan, J.M., Peliowski, A., Ainsworth, W. & Robertson, C.M. 1999. Prolonged use of pancuronium bromide and sensorineural hearing loss in childhood survivors of congenital diaphragmatic hernia. J Pediatr, 135, 233–239.
   PubMed Web of Science ®Google Scholar
• Dahle, A.J., Fowler, K.B., Wright, J.D., Boppana, S.B., Britt, W.J., et al. 2000. Longitudinal investigation of hearing disorders in children with congenital cytomegalovirus. J Am Acad Audiol, 11, 283–290.
   PubMedGoogle Scholar
• Davies, J. & Wright, G.D. 1997. Bacterial resistance to aminoglycoside antibiotics. Trends Microbiol, 5, 234–240.
   PubMed Web of Science ®Google Scholar
• Declau, F., Boudewyns, A., Van den Ende, J., Peeters, A. & van den Heyning, P. 2008. Etiologic and audiologic evaluations after universal neonatal hearing screening: analysis of 170 referred neonates. Pediatrics, 121, 1119–1126.
   PubMed Web of Science ®Google Scholar
• Dennett, K.V., Fligor, B.J., Tracy, S., Wilson, J.M., Zurakowski, D., et al. 2014. Sensorineural hearing loss in congenital diaphragmatic hernia survivors is associated with postnatal management and not defect size. J Pediatr Surg, 49, 895–899.
   PubMed Web of Science ®Google Scholar
• Edwards, M.S. & Baker, C.J. 2004. Sepsis in the newborn. In: Gershon, A.A., Hotez, P.J & Katz, S.L. (eds.) Krugman's Infectious Diseases of Children. Philadelphia, PA: Mosby, pp. 545–561.
   Google Scholar
• Eidelman, A.I. 2002. The role of the NICU in developing countries. J Perinatol, 22, 1.
   PubMedGoogle Scholar
• Erenberg, A., Lemons, J., Sia, C., Trunkel, D. & Ziring, P. 1999. Newborn and infant hearing loss: detection and intervention. American Academy of Pediatrics. Task Force on Newborn and Infant Hearing, 1998–1999. Pediatrics, 103, 527–530.
   PubMed Web of Science ®Google Scholar
• Escobar, G.J. 1999. The neonatal “sepsis work-up”: personal reflections on the development of an evidence-based approach toward newborn infections in a managed care organization. Pediatrics, 103, 360–373.
   PubMedGoogle Scholar
• Escobar, G.J. 2005. What have we learned from observational studies on neonatal sepsis? Pediatr Crit Care Med, 6, S138–S145.
   PubMedGoogle Scholar
• Fligor, B.J., Neault, M.W., Mullen, C.H., Feldman, H.A. & Jones, D.T. 2005. Factors associated with sensorineural hearing loss among survivors of extracorporeal membrane oxygenation therapy. Pediatrics, 115, 1519–1528.
   PubMed Web of Science ®Google Scholar
• Forge, A. & Schacht, J. 2000. Aminoglycoside antibiotics. Audiol Neurootol, 5, 3–22.
   PubMed Web of Science ®Google Scholar
• Fuchs, A., Zimmermann, L., Bickle Graz, M., Cherpillod, J., Tolsa, J.F., et al. 2016. Gentamicin exposure and sensorineural hearing loss in preterm infants. PLoS One, 11, e0158806.
   PubMed Web of Science ®Google Scholar
• Gaffney, M., Eichwald, J., Gaffney, C. & Alam, S. 2014. Early hearing detection and intervention among infants—hearing screening and follow-up survey, United States, 2005–2006 and 2009–2010. Morb Mortal Wkly Rep, 63, 20–16.
   Google Scholar
• Garinis, A.C., Liao, S., Cross, C.P., Galati, J., Middaugh, J.L., et al. 2017. Effect of gentamicin and levels of ambient sound on hearing screening outcomes in the neonatal intensive care unit: A pilot study. Int J Pediatr Otorhinolaryngol, 97, 42–50.
   PubMed Web of Science ®Google Scholar
• Gopel, W., Berkowski, S., Preuss, M., Ziegler, A., Kuster, H., et al. 2014. Mitochondrial mutation m.1555A > G as a risk factor for failed newborn hearing screening in a large cohort of preterm infants. BMC Pediatr, 14, 210.
   PubMed Web of Science ®Google Scholar
• Gratton, M.A. & Kamen, B.A. 1990. Potentiation of cisplatin ototoxicity by noise. J Clin Oncol, 8, 2091–2092.
   PubMed Web of Science ®Google Scholar
• Gratton, M.A., Salvi, R.J., Kamen, B.A. & Saunders, S.S. 1990. Interaction of cisplatin and noise on the peripheral auditory system. Hear Res, 50, 211–223.
   PubMed Web of Science ®Google Scholar
• Graven, S.N. 2000. Sound and the developing infant in the NICU: conclusions and recommendations for care. J Perinatol, 20, S88–S93.
   PubMedGoogle Scholar
• Guan, M.X. 2011. Mitochondrial 12S rRNA mutations associated with aminoglycoside ototoxicity. Mitochondrion, 11, 237–245.
   PubMed Web of Science ®Google Scholar
• Hall, J.W., 3rd, Smith, S.D. & Popelka, G.R. 2004. Newborn hearing screening with combined otoacoustic emissions and auditory brainstem responses. J Am Acad Audiol, 15, 414–425.
   PubMedGoogle Scholar
• Harris, T., Bardien, S., Schaaf, H.S., Petersen, L., De Jong, G., et al. 2012a. Aminoglycoside-induced hearing loss in HIV-positive and HIV-negative multidrug-resistant tuberculosis patients. S Afr Med J, 102, 363–366.
   PubMed Web of Science ®Google Scholar
• Harris, T., Peer, S. & Fagan, J.J. 2012b. Audiological monitoring for ototoxic tuberculosis, human immunodeficiency virus and cancer therapies in a developing world setting. J Laryngol Otol, 126, 548–551.
   PubMed Web of Science ®Google Scholar
• Hess, M., Finckh-Kramer, U., Bartsch, M., Kewitz, G., Versmold, H., et al. 1998. Hearing screening in at-risk neonate cohort. Int J Pediatr Otorhinolaryngol, 46, 81–89.
   PubMed Web of Science ®Google Scholar
• Hirose, K., Hartsock, J.J., Johnson, S., Santi, P. & Salt, A.N. 2014. Systemic lipopolysaccharide compromises the blood-labyrinth barrier and increases entry of serum fluorescein into the perilymph. J Assoc Res Otolaryngol, 15, 707–719.
   PubMed Web of Science ®Google Scholar
• Hoffman, D.W., Whitworth, C.A., Jones-King, K.L. & Rybak, L.P. 1988. Potentiation of ototoxicity by glutathione depletion. Ann Otol Rhinol Laryngol, 97, 36–41.
   PubMed Web of Science ®Google Scholar
• Hotz, M.A., Harris, F.P. & Probst, R. 1994. Otoacoustic emissions: an approach for monitoring aminoglycoside-induced ototoxicity. Laryngoscope, 104, 1130–1134.
   PubMed Web of Science ®Google Scholar
• Hunter, L.L., Keefe, D.H., Feeney, M.P., Fitzpatrick, D.F. & Lin, L. 2016. Longitudinal development of wideband reflectance tympanometry in normal and at-risk infants. Hear Res, 340, 3–14.
   PubMed Web of Science ®Google Scholar
• JCIH. 1973. Screening for Infant Hearing. Rockville, MD: Joint Committee on Infant Hearing, p. 1.
   Google Scholar
• JCIH. 1990. Joint Committee on Infant Hearing 1990 Position Statement. Rockville, MD: Joint Committee on Infant Hearing, pp. 1–4.
   Google Scholar
• JCIH. 2007. Year 2007 position statement: Principles and guidelines for early hearing detection and intervention programs. Pediatrics, 120, 898–921.
   PubMed Web of Science ®Google Scholar
• Johnson, J.L., White, K.R., Widen, J.E., Gravel, J.S., James, M., et al. 2005. A multicenter evaluation of how many infants with permanent hearing loss pass a two-stage otoacoustic emissions/automated auditory brainstem response newborn hearing screening protocol. Pediatrics, 116, 663–672.
   PubMed Web of Science ®Google Scholar
• Jordan, J.A., Durso, M.B., Butchko, A.R., Jones, J.G. & Brozanski, B.S. 2006. Evaluating the near-term infant for early onset sepsis: progress and challenges to consider with 16S rDNA polymerase chain reaction testing. J Mol Diagn, 8, 357–363.
   PubMed Web of Science ®Google Scholar
• Kennedy, C.R., McCann, D.C., Campbell, M.J., Law, C.M., Mullee, M., et al. 2006. Language ability after early detection of permanent childhood hearing impairment. N Engl J Med, 354, 2131–2141.
   PubMed Web of Science ®Google Scholar
• Knight, K.R., Kraemer, D.F. & Neuwelt, E.A. 2005. Ototoxicity in children receiving platinum chemotherapy: underestimating a commonly occurring toxicity that may influence academic and social development. J Clin Oncol, 23, 8588–8596.
   PubMed Web of Science ®Google Scholar
• Knight, K.R., Kraemer, D.F., Winter, C. & Neuwelt, E.A. 2007. Early changes in auditory function as a result of platinum chemotherapy: use of extended high-frequency audiometry and evoked distortion product otoacoustic emissions. J Clin Oncol, 25, 1190–1195.
   PubMed Web of Science ®Google Scholar
• Kolinsky, D.C., Hayashi, S.S., Karzon, R., Mao, J. & Hayashi, R.J. 2010. Late onset hearing loss: a significant complication of cancer survivors treated with Cisplatin containing chemotherapy regimens. J Pediatr Hematol Oncol, 32, 119–123.
   PubMed Web of Science ®Google Scholar
• Konrad-Martin, D., Wilmington, D.J., Gordon, J.S., Reavis, K.M. & Fausti, S.A. 2005. Audiological management of patients receiving aminoglycoside antibiotics. Volta Rev, 105, 229–250.
   Web of Science ®Google Scholar
• Koo, J.W., Quintanilla-Dieck, L., Jiang, M., Liu, J., Urdang, Z.D., et al. 2015. Endotoxemia-mediated inflammation potentiates aminoglycoside-induced ototoxicity. Sci Translat Med, 7, 298ra118.
   PubMed Web of Science ®Google Scholar
• Koo, J.W., Wang, Q. & Steyger, P.S. 2011. Infection-mediated vasoactive peptides modulate cochlear uptake of fluorescent gentamicin. Audiol Neurootol, 16, 347–358.
   PubMed Web of Science ®Google Scholar
• Kramer, B., Joshi, P. & Heard, C. 2016. Noise pollution levels in the pediatric intensive care unit. J Crit Care, 36, 111–115.
   PubMed Web of Science ®Google Scholar
• Kros, C.J. & Desmonds, T. 2015. Drug-induced hearing loss: Infection raises the odds. Sci Translat Med, 7, 298fs231.
   Web of Science ®Google Scholar
• Laughon, M.M., Chantala, K., Aliaga, S., Herring, A.H., Hornik, C.P., et al. 2015. Diuretic exposure in premature infants from 1997 to 2011. Am J Perinatol, 32, 49–56.
   PubMed Web of Science ®Google Scholar
• Lautermann, J., McLaren, J. & Schacht, J. 1995. Glutathione protection against gentamicin ototoxicity depends on nutritional status. Hear Res, 86, 15–24.
   PubMed Web of Science ®Google Scholar
• Lestner, J.M., Hill, L.F., Heath, P.T. & Sharland, M. 2016. Vancomycin toxicity in neonates: a review of the evidence. Curr Opin Infect Dis, 29, 237–247.
   PubMed Web of Science ®Google Scholar
• Li, H., Kachelmeier, A., Furness, D.N. & Steyger, P.S. 2015. Local mechanisms for loud sound-enhanced aminoglycoside entry into outer hair cells. Front Cell Neurosci, 9, 130.
   PubMed Web of Science ®Google Scholar
• Li, H., Wang, Q. & Steyger, P.S. 2011. Acoustic trauma increases cochlear and hair cell uptake of gentamicin. PLoS One, 6, e19130.
   PubMed Web of Science ®Google Scholar
• Lin, C.D., Kao, M.C., Tsai, M.H., Lai, C.H., Wei, I.H., et al. 2011. Transient ischemia/hypoxia enhances gentamicin ototoxicity via caspase-dependent cell death pathway. Lab Invest, 91, 1092–1106.
   PubMed Web of Science ®Google Scholar
• Linden Phillips, L., Bitner-Glindzicz, M., Lench, N., Steel, K.P., Langford, C., et al. 2013. The future role of genetic screening to detect newborns at risk of childhood-onset hearing loss. Int J Audiol, 52, 124–133.
   PubMed Web of Science ®Google Scholar
• Lonsbury-Martin, B.L. & Martin, G.K. 2001. Evoked otoacoustic emissions as objective screeners for ototoxicity. Semin Hear, 22, 377–391.
   Google Scholar
• Machado, J.R., Soave, D.F., da Silva, M.V., de Menezes, L.B., Etchebehere, R.M., et al. 2014. Neonatal sepsis and inflammatory mediators. Mediators Inflamm, 2014, 269681.
   PubMed Web of Science ®Google Scholar
• Manian, F.A., Stone, W.J. & Alford, R.H. 1990. Adverse antibiotic effects associated with renal insufficiency. Rev Infect Dis, 12, 236–249.
   PubMedGoogle Scholar
• Masumoto, K., Nagata, K., Uesugi, T., Yamada, T. & Taguchi, T. 2007. Risk factors for sensorineural hearing loss in survivors with severe congenital diaphragmatic hernia. Eur J Pediatr, 166, 607–612.
   PubMed Web of Science ®Google Scholar
• Medhat, H., Khashana, A. & El Kalioby, M. 2016. Multivariate logistic regression analysis for the significant neonatal and maternal risk factors related to neonatal sepsis. Int J Infect, 3, e38290.
   Google Scholar
• Mohr, P.E., Feldman, J.J., Dunbar, J.L., McConkey-Robbins, A., Niparko, J.K., et al. 2000. The societal costs of severe to profound hearing loss in the United States. Int J Technol Assess Health Care, 16, 1120–1135.
   PubMed Web of Science ®Google Scholar
• Mulheran, M. & Degg, C. 1997. Comparison of distortion product OAE generation between a patient group requiring frequent gentamicin therapy and control subjects. Br J Audiol, 31, 5–9.
   PubMed Web of Science ®Google Scholar
• Norton, S.J., Gorga, M.P., Widen, J.E., Folsom, R.C., Sininger, Y., et al. 2000. Identification of neonatal hearing impairment: evaluation of transient evoked otoacoustic emission, distortion product otoacoustic emission, and auditory brain stem response test performance. Ear Hear, 21, 508–528.
   PubMed Web of Science ®Google Scholar
• Oh, G.S., Kim, H.J., Choi, J.H., Shen, A., Kim, C.H., et al. 2011. Activation of lipopolysaccharide-TLR4 signaling accelerates the ototoxic potential of cisplatin in mice. J Immunol, 186, 1140–1150.
   PubMed Web of Science ®Google Scholar
• Olds, C. & Oghalai, J.S. 2016. Bilirubin-induced audiologic injury in preterm infants. Clin Perinatol, 43, 313–323.
   PubMed Web of Science ®Google Scholar
• Osterman, M.J.K., Martin, J.A., Mathews, T.J. & Hamilton, B.E. 2011. Expanded data from the new birth certificate, 2008. Natl Vital Stat Rep, 59, 1–28.
   Google Scholar
• Pacifici, G.M. 2012. Clinical pharmacology of the loop diuretics furosemide and bumetanide in neonates and infants. Paediatr Drugs, 14, 233–246.
   PubMed Web of Science ®Google Scholar
• Paulos, C.M., Wrzesinski, C., Kaiser, A., Hinrichs, C.S., Chieppa, M., et al. 2007. Microbial translocation augments the function of adoptively transferred self/tumor-specific CD8+ T cells via TLR4 signaling. J Clin Invest, 117, 2197–2204.
   PubMed Web of Science ®Google Scholar
• Remington, J.S. 2011. Infectious Diseases of the Fetus and Newborn Infant. Philadelphia, PA: Saunders/Elsevier.
   Google Scholar
• Robertson, C.M., Cheung, P.Y., Haluschak, M.M., Elliott, C.A. & Leonard, N.J. 1998. High prevalence of sensorineural hearing loss among survivors of neonatal congenital diaphragmatic hernia. Western Canadian ECMO Follow-up Group. Am J Otol, 19, 730–736.
   PubMedGoogle Scholar
• Robertson, C.M., Howarth, T.M., Bork, D.L. & Dinu, I.A. 2009. Permanent bilateral sensory and neural hearing loss of children after neonatal intensive care because of extreme prematurity: a thirty-year study. Pediatrics, 123, e797–e807.
   PubMed Web of Science ®Google Scholar
• Robertson, C.M., Tyebkhan, J.M., Peliowski, A., Etches, P.C. & Cheung, P.Y. 2006. Ototoxic drugs and sensorineural hearing loss following severe neonatal respiratory failure. Acta Paediatr, 95, 214–223.
   PubMed Web of Science ®Google Scholar
• Rubin, L.G., Sanchez, P.J., Siegel, J., Levine, G., Saiman, L., et al. 2002. Evaluation and treatment of neonates with suspected late-onset sepsis: a survey of neonatologists' practices. Pediatrics, 110, e42.
   PubMed Web of Science ®Google Scholar
• Rybak, L.P. 1982. Pathophysiology of furosemide ototoxicity. J Otolaryngol, 11, 127–133.
   PubMedGoogle Scholar
• Rybak, L.P. 1988. Ototoxicity of ethacrynic acid (a persistent clinical problem). J Laryngol Otol, 102, 518–520.
   PubMed Web of Science ®Google Scholar
• Saha, A., Gupta, V., Kapoor, K., Dubey, N.K., Lal, P., et al. 2013. Hearing status in children with frequently relapsing and steroid resistant nephrotic syndrome. Pediatr Nephrol, 28, 439–445.
   PubMed Web of Science ®Google Scholar
• Shapiro, S.M. & Popelka, G.R. 2011. Auditory impairment in infants at risk for bilirubin-induced neurologic dysfunction. Semin Perinatol, 35, 162–170.
   PubMed Web of Science ®Google Scholar
• Simiyu, D.E. 2003. Morbidity and mortality of neonates admitted in general paediatric wards at Kenyatta National Hospital. East Afr Med J, 80, 611–616.
   PubMedGoogle Scholar
• Sininger, Y.S., Doyle, K.J. & Moore, J.K. 1999. The case for early identification of hearing loss in children. Auditory system development, experimental auditory deprivation, and development of speech perception and hearing. Pediatr Clin North Am, 46, 1–14.
   PubMed Web of Science ®Google Scholar
• Smit, E., Liu, X., Gill, H., Sabir, H., Jary, S., et al. 2013. Factors associated with permanent hearing impairment in infants treated with therapeutic hypothermia. J Pediatr, 163, 995–1000.
   PubMed Web of Science ®Google Scholar
• So, T.Y. 2009. Use of ototoxic medications in neonates-the need for follow-up hearing test. J Pediatr Pharmacol Ther, 14, 200–203.
   PubMedGoogle Scholar
• Stelmachowicz, P.G., Pittman, A.L., Hoover, B.M., Lewis, D.E. & Moeller, M.P. 2004. The importance of high-frequency audibility in the speech and language development of children with hearing loss. Arch Otolaryngol Head Neck Surg, 130, 556–562.
   PubMed Web of Science ®Google Scholar
• Stika, C.J., Eisenberg, L.S., Johnson, K.C., Henning, S.C., Colson, B.G., et al. 2015. Developmental outcomes of early-identified children who are hard of hearing at 12 to 18 months of age. Early Hum Dev, 91, 47–55.
   PubMed Web of Science ®Google Scholar
• Thompson, D.C., McPhillips, H., Davis, R.L., Lieu, T.L., Homer, C.J., et al. 2001. Universal newborn hearing screening: summary of evidence. JAMA, 286, 2000–2010.
   PubMed Web of Science ®Google Scholar
• Veal, G.J., Errington, J., Hayden, J., Hobin, D., Murphy, D., et al. 2015. Carboplatin therapeutic monitoring in preterm and full-term neonates. Eur J Cancer, 51, 2022–2030.
   PubMed Web of Science ®Google Scholar
• Vedovato, S., Lo Iacono, A., Morando, C., Suppiej, A., Orzan, E., et al. 2015. Sensorineural hearing loss in very low birth weight infants with histological chorioamnionitis. J Mater-Fetal Neonat Med, 28, 895–899.
   PubMed Web of Science ®Google Scholar
• Vella-Brincat, J.W., Begg, E.J., Robertshawe, B.J., Lynn, A.M., Borrie, T.L., et al. 2011. Are gentamicin and/or vancomycin associated with ototoxicity in the neonate? A retrospective audit. Neonatology, 100, 186–193.
   PubMed Web of Science ®Google Scholar
• Wachman, E.M. & Lahav, A. 2011. The effects of noise on preterm infants in the NICU. Arch Dis Child Fetal Neonatal Ed, 96, F305–F309.
   PubMed Web of Science ®Google Scholar
• Ward, E., DeSantis, C., Robbins, A., Kohler, B. & Jemal, A. 2014. Childhood and adolescent cancer statistics, 2014. CA Cancer J Clin, 64, 83–103.
   PubMed Web of Science ®Google Scholar
• Weissman, S.J., Hansen, N.I., Zaterka-Baxter, K., Higgins, R.D. & Stoll, B.J. 2016. Emergence of antibiotic resistance-associated clones among Escherichia coli recovered from newborns with early-onset sepsis and meningitis in the United States, 2008–2009. J Pediatric Infect Dis Soc, 5, 269–276.
   PubMed Web of Science ®Google Scholar
• Werner, L.A. & Boike, K. 2001. Infants' sensitivity to broadband noise. J Acoust Soc Am, 109, 2103–2111.
   PubMed Web of Science ®Google Scholar
• Wiles, J.R., Vinks, A.A. & Akinbi, H. 2013. Federal legislation and the advancement of neonatal drug studies. J Pediatr, 162, 12–15.
   PubMed Web of Science ®Google Scholar
• Williams, T.R., Alam, S., Gaffney, M. & Centers for Disease C. & Prevention 2015. Progress in identifying infants with hearing loss—United States, 2006–2012. MMWR, 64, 351–356.
   PubMed Web of Science ®Google Scholar
• Yoshinaga-Itano, C., Sedey, A.L., Coulter, D.K. & Mehl, A.L. 1998. Language of early- and later-identified children with hearing loss. Pediatrics, 102, 1161–1171.
   PubMed Web of Science ®Google Scholar
• Zahr, L.K. & Balian, S. 1995. Responses of premature infants to routine nursing interventions and noise in the NICU. Nurs Res, 44, 179–185.
   PubMed Web of Science ®Google Scholar
• Zimmerman, E. & Lahav, A. 2013. Ototoxicity in preterm infants: effects of genetics, aminoglycosides, and loud environmental noise. J Perinatol, 33, 3–8.
   PubMed Web of Science ®Google Scholar